Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways.
Scientific Reports
Quinn, Leonard M LM; Haldenby, Sam S; Antzcak, Philip P; Fowler, Anna A; Bullock, Katie K; Kenny, John J; Gilbert, Timothy T; Andrews, Timothy T; Diaz-Nieto, Rafael R; Fenwick, Stephen S; Jones, Robert R; Costello-Goldring, Eithne E; Poston, Graeme G; Greenhalf, William W; Palmer, Daniel D; Malik, Hassan H; Goldring, Chris C
Publication Date: 2023-04-24
Variant appearance in text: PIK3CA: 35G>A; Gly12Asp
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance.
Cancer Research Communications
Johnson, Zoë Z; Tarantelli, Chiara C; Civanelli, Elisa E; Cascione, Luciano L; Spriano, Filippo F; Fraser, Amy A; Shah, Pritom P; Nomanbhoy, Tyzoon T; Napoli, Sara S; Rinaldi, Andrea A; Niewola-Staszkowska, Karolina K; Lahn, Michael M; Perrin, Dominique D; Wenes, Mathias M; Migliorini, Denis D; Bertoni, Francesco F; van der Veen, Lars L; Di Conza, Giusy G
Knocking-Down CD147/EMMPRIN Expression in CT26 Colon Carcinoma Forces the Cells into Cellular and Angiogenic Dormancy That Can Be Reversed by Interactions with Macrophages.
Biomedicines
Feigelman, Gabriele G; Simanovich, Elina E; Brockmeyer, Phillipp P; Rahat, Michal A MA
Atherosclerosis is a smooth muscle cell-driven tumor-like disease.
Biorxiv : The Preprint Server For Biology
Pan, Huize H; Ho, Sebastian E SE; Xue, Chenyi C; Cui, Jian J; Ross, Leila S LS; Li, Fang F; Solomon, Robert A RA; Connolly, E Sander ES; Reilly, Muredach P MP
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection.
Therapeutic Advances In Medical Oncology
Ottaiano, Alessandro A; Santorsola, Mariachiara M; Circelli, Luisa L; Cascella, Marco M; Petrillo, Nadia N; Perri, Francesco F; Casillo, Marika M; Granata, Vincenza V; Ianniello, Monica M; Izzo, Francesco F; Picone, Carmine C; Correra, Marco M; Petrillo, Antonella A; Sirica, Roberto R; Misso, Gabriella G; Delrio, Paolo P; Nasti, Guglielmo G; Savarese, Giovanni G; Caraglia, Michele M
Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1.
Cancer Research Communications
Kurupi, Richard R; Floros, Konstantinos V KV; Jacob, Sheeba S; Chawla, Ayesha T AT; Cai, Jinyang J; Hu, Bin B; Puchalapalli, Madhavi M; Coon, Colin M CM; Khatri, Rishabh R; Crowther, Giovanna Stein GS; Egan, Regina K RK; Murchie, Ellen E; Greninger, Patricia P; Dalton, Krista M KM; Ghotra, Maninderjit S MS; Boikos, Sosipatros A SA; Koblinski, Jennifer E JE; Harada, Hisashi H; Sun, Yue Y; Morgan, Iain M IM; Basu, Devraj D; Dozmorov, Mikhail G MG; Benes, Cyril H CH; Faber, Anthony C AC
Case report: Undifferentiated sarcoma with multiple tumors involved in Lynch syndrome: Unexpected favorable outcome to sintilimab combined with chemotherapy.
Frontiers In Oncology
Liu, Jiaying J; Chang, Xiaona X; Xiao, Guixiang G; Zhong, Jingmin J; Huang, Bo B; Zhang, Jiwei J; Gao, Beibei B; Peng, Gang G; Nie, Xiu X
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer.
British Journal Of Cancer
Fernandez-Garcia, Daniel D; Nteliopoulos, Georgios G; Hastings, Robert K RK; Rushton, Amelia A; Page, Karen K; Allsopp, Rebecca C RC; Ambasager, Bana B; Gleason, Kelly K; Guttery, David S DS; Ali, Simak S; Charles Coombes, R R; Shaw, Jacqueline A JA
Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia.
Cell Stem Cell
Vasquez, Ester Gil EG; Nasreddin, Nadia N; Valbuena, Gabriel N GN; Mulholland, Eoghan J EJ; Belnoue-Davis, Hayley L HL; Eggington, Holly R HR; Schenck, Ryan O RO; Wouters, Valérie M VM; Wirapati, Pratyaksha P; Gilroy, Kathryn K; Lannagan, Tamsin R M TRM; Flanagan, Dustin J DJ; Najumudeen, Arafath K AK; Omwenga, Sulochana S; McCorry, Amy M B AMB; Easton, Alistair A; Koelzer, Viktor H VH; East, James E JE; Morton, Dion D; Trusolino, Livio L; Maughan, Timothy T; Campbell, Andrew D AD; Loughrey, Maurice B MB; Dunne, Philip D PD; Tsantoulis, Petros P; Huels, David J DJ; Tejpar, Sabine S; Sansom, Owen J OJ; Leedham, Simon J SJ
Molecular characterization of colorectal cancer related peritoneal metastatic disease.
Nature Communications
Lenos, Kristiaan J KJ; Bach, Sander S; Ferreira Moreno, Leandro L; Ten Hoorn, Sanne S; Sluiter, Nina R NR; Bootsma, Sanne S; Vieira Braga, Felipe A FA; Nijman, Lisanne E LE; van den Bosch, Tom T; Miedema, Daniel M DM; van Dijk, Erik E; Ylstra, Bauke B; Kulicke, Ruth R; Davis, Fred P FP; Stransky, Nicolas N; Smolen, Gromoslaw A GA; Coebergh van den Braak, Robert R J RRJ; IJzermans, Jan N M JNM; Martens, John W M JWM; Hallam, Sally S; Beggs, Andrew D AD; Kops, Geert J P L GJPL; Lansu, Nico N; Bastiaenen, Vivian P VP; Klaver, Charlotte E L CEL; Lecca, Maria C MC; El Makrini, Khalid K; Elbers, Clara C CC; Dings, Mark P G MPG; van Noesel, Carel J M CJM; Kranenburg, Onno O; Medema, Jan Paul JP; Koster, Jan J; Koens, Lianne L; Punt, Cornelis J A CJA; Tanis, Pieter J PJ; de Hingh, Ignace H IH; Bijlsma, Maarten F MF; Tuynman, Jurriaan B JB; Vermeulen, Louis L
Antibody-mediated blockade for galectin-3 binding protein in tumor secretome abrogates PDAC metastasis.
Proceedings Of The National Academy Of Sciences Of The United States Of America
Choi, Yeon-Sook YS; Kim, Myung Ji MJ; Choi, Eun A EA; Kim, Sinae S; Lee, Eun Ji EJ; Park, Min Ji MJ; Kim, Mi-Ju MJ; Kim, Yeon Wook YW; Ahn, Hee-Sung HS; Jung, Jae Yun JY; Jang, Gayoung G; Kim, Yongsub Y; Kim, Hyori H; Kim, Kyunggon K; Kim, Jin Young JY; Hong, Seung-Mo SM; Kim, Song Cheol SC; Chang, Suhwan S
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
Journal Of Experimental & Clinical Cancer Research : Cr
Voon, Pei Jye PJ; Chen, Eric X EX; Chen, Helen X HX; Lockhart, Albert C AC; Sahebjam, Solmaz S; Kelly, Karen K; Vaishampayan, Ulka N UN; Subbiah, Vivek V; Razak, Albiruni R AR; Renouf, Daniel J DJ; Hotte, Sebastien J SJ; Singh, Arti A; Bedard, Philippe L PL; Hansen, Aaron R AR; Ivy, S Percy SP; Wang, Lisa L; Stayner, Lee-Anne LA; Siu, Lillian L LL; Spreafico, Anna A
Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
Journal Of Experimental & Clinical Cancer Research : Cr
Voon, Pei Jye PJ; Chen, Eric X EX; Chen, Helen X HX; Lockhart, Albert C AC; Sahebjam, Solmaz S; Kelly, Karen K; Vaishampayan, Ulka N UN; Subbiah, Vivek V; Razak, Albiruni R AR; Renouf, Daniel J DJ; Hotte, Sebastien J SJ; Singh, Arti A; Bedard, Philippe L PL; Hansen, Aaron R AR; Ivy, S Percy SP; Wang, Lisa L; Stayner, Lee-Anne LA; Siu, Lillian L LL; Spreafico, Anna A
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Bmc Cancer
Karachaliou, Georgia Sofia GS; Alkallas, Rached R; Carroll, Sarah B SB; Caressi, Chongshan C; Zakria, Danny D; Patel, Nirali M NM; Trembath, Dimitri G DG; Ezzell, Jennifer A JA; Pegna, Guillaume J GJ; Googe, Paul B PB; Galeotti, Jonathan P JP; Ayvali, Fatih F; Collichio, Frances A FA; Lee, Carrie B CB; Ollila, David W DW; Gulley, Margaret L ML; Johnson, Douglas B DB; Kim, Kevin B KB; Watson, Ian R IR; Moschos, Stergios J SJ
The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Bmc Cancer
Karachaliou, Georgia Sofia GS; Alkallas, Rached R; Carroll, Sarah B SB; Caressi, Chongshan C; Zakria, Danny D; Patel, Nirali M NM; Trembath, Dimitri G DG; Ezzell, Jennifer A JA; Pegna, Guillaume J GJ; Googe, Paul B PB; Galeotti, Jonathan P JP; Ayvali, Fatih F; Collichio, Frances A FA; Lee, Carrie B CB; Ollila, David W DW; Gulley, Margaret L ML; Johnson, Douglas B DB; Kim, Kevin B KB; Watson, Ian R IR; Moschos, Stergios J SJ
The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.
The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.